Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
StroMed + platelet-rich plasma
- Development stage
- Unknown
- Lead developer
- VivaTech
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intraarticular
01
Overview
StroMed + platelet-rich plasma (PRP) is an autologous cell therapy developed by VivaTech for the treatment of osteoarthritis in the knee, hip, and shoulder. The therapy utilizes StroMed, a proprietary population of non-cultured, adipose-derived stromal/stem cells (ADSCs) isolated from the patient's own fat tissue using a chemical-free ultrasonic cavitation process. These cells are combined with autologous PRP and administered via direct intra-articular injection. The mechanism of action involves the modulation of inflammation and promotion of tissue regeneration within the damaged joint through a heterogeneous cell population that includes stem cells, endothelial progenitor cells, and immune cells with anti-inflammatory properties.
- Brand names
- StroMed + platelet rich plasma
- Other names
- StroMed + PRPautologous adipose-derived stromal/stem cells + platelet-rich plasma
Beyond the preview
Go deeper on StroMed + platelet-rich plasma.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on StroMed + platelet-rich plasma.